Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Phytochem Anal ; 23(4): 387-95, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22025447

RESUMO

INTRODUCTION: The quality control of Magnoliae officinalis Cortex, a commonly used traditional Chinese medicine, is currently based on the assay of the two active compounds, honokiol and magnolol, by TLC or HPLC. OBJECTIVE: To compare ¹H-NMR-based metabolomics with the HPLC method for controlling the quality of Magnoliae officinalis Cortex. To identify the metabolites contributing to the differences between the samples and to discriminate different medicinal parts and geographic origins of these samples by ¹H-NMR-based metabolomics. METHODOLOGY: ¹H-NMR and several multivariate analysis techniques were applied to analyse the extracts of 18 batches of Magnoliae officinalis Cortex commercial samples, and the contents of honokiol and magnolol in these samples were determined by HPLC. The correlation analysis between the data from ¹H-NMR and HPLC was performed with the mixOmics software based on an unsupervised method. RESULTS: Honokiol and magnolol were the main compounds responsible for the discrimination of samples from different batches, thus proving that the choice of these two compounds as markers for quality assessment by HPLC is relevant. The two sources of Magnoliae officinalis Cortex recorded in the Chinese Pharmacopoeia, Magnolia officinalis and Magnolia officinalis var. biloba, could be differentiated from ¹H-NMR data, but the pattern recognition analysis by PLS-DA was unsuccessful in discriminating samples from various geographical origins. CONCLUSION: The combination of ¹H-NMR that gives a comprehensive profile of the metabolites and HPLC that targets two biomarkers is an efficient means for a better quality control of Magnoliae officinalis Cortex.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Espectroscopia de Ressonância Magnética/métodos , Magnolia/química , Metabolômica/métodos , Software , Compostos de Bifenilo/química , China , Medicamentos de Ervas Chinesas/análise , Medicamentos de Ervas Chinesas/química , Ecossistema , Lignanas/química , Metaboloma , Análise Multivariada , Controle de Qualidade , Sensibilidade e Especificidade
2.
J Proteome Res ; 8(12): 5580-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19813770

RESUMO

The plasma of patients with stable carotid atherosclerosis (n = 9), and healthy subjects (n = 10) have been fingerprinted with both GC-MS and (1)H NMR. Principal component analysis (PCA), partial least-squares-discriminant analysis (PLS-DA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA) have been applied to the profiles from each technique both separately and in combination. These techniques complement each other and enable a clearer picture of the biological samples to be interpreted not only for classification purposes, but also more importantly to define the metabolic state of patients with carotid atherosclerosis. The results showed at least 24 metabolites that were significantly modified in the group of atherosclerotic patients by this nontargeted procedure. Most of the changes can be associated to alterations of the metabolism characteristics of insulin resistance that can be strongly related to the metabolic syndrome. In addition, correlations among variables accounting for the classification show amino acids as variables whose changes showed a high degree of correlation. GC-MS and (1)H NMR fingerprints can provide complementary information in the identification of altered metabolic pathways in patients with carotid atherosclerosis. Moreover, correlations among the results with both techniques, instead of a single study, can provide a deeper insight into the patient state.


Assuntos
Aterosclerose/metabolismo , Metaboloma , Metabolômica/métodos , Aminoácidos/análise , Estudos de Casos e Controles , Análise Discriminante , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Resistência à Insulina , Espectroscopia de Ressonância Magnética , Síndrome Metabólica/metabolismo , Análise de Componente Principal
3.
Bioorg Med Chem ; 17(15): 5396-407, 2009 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-19595598

RESUMO

Ciprofloxacin (CP), an antibiotic has been shown to have antiproliferative and apoptotic activities in several cancer cell lines. Moreover, several reports have highlighted the interest of increasing the lipophilicity to improve the antitumor efficacy. These studies have led us to synthesize new CP derivatives of various lipophilicities and to evaluate their activity in five human cancer cell lines. With an easy and cost-efficient procedure, 31 7-((4-substituted)piperazin-1-yl) derivatives of CP were prepared that displayed IC(50) values ranging from microM to mM concentrations and are non-toxic in vivo in healthy mice as shown by their maximal tolerated dose (MTD) indices >80 mg/kg. Several derivatives displayed higher in vitro antitumor activity than parent CP however this was not dependent on the lipophilicity of the substituent. Among all synthesized derivatives, the most potent were 2 and 6h whose IC(50) values were 10 microM in three (derivative 2) or four (derivative 6h) cancer cell lines.


Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Ciprofloxacina/análogos & derivados , Ciprofloxacina/farmacologia , Piperazinas/química , Piperazinas/farmacologia , Animais , Antineoplásicos/toxicidade , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Ciprofloxacina/síntese química , Ciprofloxacina/toxicidade , Humanos , Dose Máxima Tolerável , Camundongos , Neoplasias/tratamento farmacológico , Piperazina , Piperazinas/síntese química , Piperazinas/toxicidade
4.
J Pharm Biomed Anal ; 59: 58-66, 2012 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-22030075

RESUMO

iErect, a new dietary supplement marketed as "100% natural" and sold over the Internet, was analyzed. It contains thiosildenafil, a sildenafil analogue already reported as an adulterant in herbal formulations, and a new compound whose structure was elucidated after isolation using NMR, MS and IR. It was named depiperazinothiosildenafil as it results from the hydrolytic cleavage of the S-N bond of the sulfonamide group of thiosildenafil. A capsule of iErect contains a very high amount (≈220mg) of thiosildenafil and ≈30mg of depiperazinothiosildenafil, which places consumers at risk for potentially serious side-effects.


Assuntos
Suplementos Nutricionais/análise , Suplementos Nutricionais/normas , Contaminação de Medicamentos , Piperazinas/isolamento & purificação , Preparações de Plantas/análise , Preparações de Plantas/normas , Pirimidinas/isolamento & purificação , Sulfonas/isolamento & purificação , Tionas/isolamento & purificação , Cápsulas , Cromatografia Líquida de Alta Pressão , Contaminação de Medicamentos/legislação & jurisprudência , Espectroscopia de Ressonância Magnética , Piperazinas/química , Purinas/química , Purinas/isolamento & purificação , Pirimidinas/química , Citrato de Sildenafila , Espectroscopia de Infravermelho com Transformada de Fourier , Sulfonas/química , Espectrometria de Massas em Tandem , Tionas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA